tiprankstipranks
Fuji Pharma Co., Ltd. (JP:4554)
:4554
Japanese Market
4554
Fuji Pharma Co., Ltd.
RESEARCH TOOLSreports

Fuji Pharma Co., Ltd. (4554) Financial Statements

0 Followers

Fuji Pharma Co., Ltd. Financial Overview

Fuji Pharma Co., Ltd.'s market cap is currently ¥63.11B. The company's EPS TTM is ¥13.28; its P/E ratio is 35.63; and it has a dividend yield of 2.39%. Fuji Pharma Co., Ltd. is scheduled to report earnings on February 5, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 24Sep 23Sep 22Sep 21
Income Statement
Total Revenue¥ 51.68B¥ 46.14B¥ 40.89B¥ 35.43B¥ 33.99B
Gross Profit¥ 19.29B¥ 16.51B¥ 15.37B¥ 13.62B¥ 14.13B
Operating Income¥ 4.99B¥ 3.88B¥ 3.86B¥ 3.78B¥ 3.35B
EBITDA¥ 8.96B¥ 7.56B¥ 6.88B¥ 6.52B¥ 5.46B
Net Income¥ 3.00B¥ 6.15B¥ 3.44B¥ 2.70B¥ 2.43B
Balance Sheet
Cash & Short-Term Investments¥ 7.25B¥ 4.58B¥ 2.32B¥ 3.55B¥ 10.20B
Total Assets¥ 93.63B¥ 90.58B¥ 86.40B¥ 75.97B¥ 64.26B
Total Debt¥ 30.94B¥ 29.25B¥ 28.95B¥ 24.57B¥ 18.66B
Net Debt¥ 23.69B¥ 24.67B¥ 26.62B¥ 21.02B¥ 8.46B
Total Liabilities¥ 46.72B¥ 45.01B¥ 45.22B¥ 40.17B¥ 31.58B
Stockholders' Equity¥ 46.91B¥ 45.56B¥ 41.17B¥ 35.80B¥ 32.68B
Cash Flow
Free Cash Flow¥ 3.82B¥ 1.37B¥ -1.41B¥ -5.75B¥ 2.20B
Operating Cash Flow¥ 5.80B¥ 4.15B¥ 1.92B¥ -658.00M¥ 5.99B
Investing Cash Flow¥ -4.22B¥ -1.66B¥ -5.24B¥ -11.27B¥ -2.35B
Financing Cash Flow¥ 954.00M¥ -435.00M¥ 1.92B¥ 5.09B¥ -5.43B
Currency in JPY

Fuji Pharma Co., Ltd. Earnings and Revenue History

Income Statement >

Fuji Pharma Co., Ltd. Debt to Assets

Balance Sheet >

Fuji Pharma Co., Ltd. Cash Flow

Cash Flow >

Fuji Pharma Co., Ltd. Forecast EPS vs Actual EPS

Earnings >